Signaling Crosstalks: EGFR and TAZ in Breast Cancer
Breast cancer is driven by multiple molecular aberrations, transforming benign epithelial cells into metastatic cancer. Identification of key signaling nodes underlying metastasis and resistance to treatment is crucial to improving targeted therapies. This review examines two oncogenes driving ep...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
The University of Arizona.
2017
|
| Online Access: | http://hdl.handle.net/10150/625241 http://arizona.openrepository.com/arizona/handle/10150/625241 |